InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
0.00%
)
US TECH 100
19,200.40
(
0.19%
)
Dow Jones
39,118.86
(
0.00%
)
Brent Oil
85.54
(
0.50%
)
Bitcoin
62,802.40
(
0.32%
)
Post# of 252444
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: None

Tuesday, 09/25/2012 8:26:23 AM

Tuesday, September 25, 2012 8:26:23 AM

Post# of 252444
BMRN and CELGZ articles on Thestreet.com

BMRN:
Biomarin: Four Clinical Trial Events to Watch Before Year End
IMO the author left out the 2nd most important catalyst BMN-701 (Pompe) granted its open label but if the data is good it could be as important than GALNS (though further off). Also I think if the data are good GALNS is closer to a 1B market opportunity.

http://www.thestreet.com/story/11717700/2/biomarin-four-clinical-trial-events-to-watch-before-year-end.html

CELGZ:
Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data
Nice write up by Jim S.

http://www.thestreet.com/story/11717470/1/celgene-cvr-upside-into-abraxane-pancreatic-cancer-trial-data.html
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up